Study guide

2.1 Pulse Oximetry, Pre/Postductal & Transcutaneous Monitoring

NBRC RRT-NPS Neonatal/Pediatric Specialist Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Neonatal and Pediatric Patient Assessment

1.1 Maternal, Obstetric & Perinatal History 1.2 Fetal Surveillance & Antepartum Diagnostics 1.3 Gestational Age & Baseline Neonatal Examination 1.4 Apgar, Respiratory Distress & Thoracic Assessment 1.5 Pediatric Assessment Triangle & Vital Signs 1.6 Neurologic Assessment, Respiratory Failure & Triage

2 Chapter 2: Diagnostic Evaluation & Gas Exchange Monitoring

2.1 Pulse Oximetry, Pre/Postductal & Transcutaneous Monitoring 2.2 Capnography, Waveforms & Dead-Space Evaluation 2.3 Arterial & Capillary Blood-Gas Sampling 2.4 Umbilical Lines, Acid-Base & Laboratory Evaluation 2.5 Chest Imaging & Airway Radiography 2.6 Pulmonary Function, Bronchoscopy & Specimen Diagnostics

3 Chapter 3: Airway Management & Secretion Clearance

3.1 Pediatric Airway Anatomy & ETT Sizing 3.2 Cuffed Airways, Intubation & Difficult-Airway Management 3.3 Tracheostomy Devices & Routine Care 3.4 Tracheostomy Emergencies, Speaking & Decannulation 3.5 Airway Suctioning Technique & Safety 3.6 Airway Clearance, Home Care & Discharge Planning

4 Chapter 4: Pharmacology & Medical Gas Therapy

4.1 Aerosol Physics & Delivery Devices 4.2 Respiratory & Systemic Pharmacology 4.3 Oxygen Interfaces & Delivery Systems 4.4 Oxygen Blenders, Targets & Toxicity 4.5 HFNC Physiology, Sizing & Flow 4.6 HFNC Indications, Monitoring & Escalation

5 Chapter 5: Shared Neonatal & Pediatric Pulmonary Disorders

5.1 Neonatal RDS Pathophysiology & Management 5.2 TTN, Pneumonia & the Neonatal Differential 5.3 Meconium Aspiration & PPHN 5.4 BPD, Apnea & Chronic Neonatal Lung Disease 5.5 Bronchiolitis, Croup & Epiglottitis 5.6 Asthma, Cystic Fibrosis & Foreign-Body Aspiration

6 Chapter 6: Resuscitation, Emergency Protocols & Patient Safety

6.1 NRP Cord Management, Initial Steps & Ventilation 6.2 NRP Corrective Steps, Compressions & Medications 6.3 PALS Assessment, CPR & Cardiac Arrest 6.4 PALS Dysrhythmia & Shock Management 6.5 Neonatal & Pediatric Transport 6.6 Patient Safety, Teamwork & Family-Centered Care

7 Chapter 7: Noninvasive & Conventional Mechanical Ventilation

7.1 Bubble CPAP & Neonatal NIV 7.2 Pediatric NIV, Interfaces & Failure Recognition 7.3 Conventional Ventilation Physics & Modes 7.4 Initial Settings & ABG-Guided Titration 7.5 Ventilator Scalars & Loops 7.6 Ventilator Dyssynchrony & Troubleshooting 7.7 Weaning Readiness & Spontaneous Breathing Trials 7.8 Extubation & Post-Extubation Airway Risk

8 Chapter 8: High-Frequency Ventilation & Advanced Modes

8.1 HFOV Mechanics & Gas Transport 8.2 HFOV Controls & Clinical Management 8.3 HFJV Circuit & Controls 8.4 HFJV Servo Pressure & Clinical Indications 8.5 NAVA, Edi & Proportional Support 8.6 APRV in Pediatric Respiratory Failure

9 Chapter 9: Specialty Inhaled Gases & Exogenous Surfactant Therapy

9.1 Inhaled Nitric Oxide: Mechanism, Indications & Dose 9.2 Inhaled Nitric Oxide: Toxicity, Monitoring & Weaning 9.3 Heliox Physics & Delivery 9.4 Volatile Anesthetic & Subambient Gas Therapy 9.5 Surfactant Biology, Products & Dosing 9.6 Surfactant Administration & Response

10 Chapter 10: Pediatric ARDS & Parenchymal Critical Illness

10.1 PALICC-2 Diagnosis & Severity 10.2 PALICC-2 NIV & Possible PARDS 10.3 PARDS Lung-Protective Ventilation 10.4 PARDS Refractory Hypoxemia & Adjuncts 10.5 PIE & Pneumothorax Recognition 10.6 Thoracic Decompression & Chest Drains

11 Chapter 11: Congenital Heart Disease & Hemodynamic Management

11.1 Left-to-Right Shunts & Qp/Qs Physiology 11.2 Acyanotic Lesions & Respiratory Management 11.3 Cyanotic Lesions & the Five Ts 11.4 Ductal Dependence, PGE1 & the Hyperoxia Test 11.5 Single-Ventricle Physiology & Staged Palliation 11.6 Gas Balancing, Hemodynamics & NIRS

12 Chapter 12: Advanced Critical Care: ECMO, Neurotrauma & Palliative Care

12.1 ECMO Candidacy & Modality 12.2 ECMO Circuit, Lung Rest & Anticoagulation 12.3 Neurotrauma, ICP & Ventilation 12.4 Neonatal Therapeutic Hypothermia & Respiratory Care 12.5 Death by Neurologic Criteria: Examination & Apnea Testing 12.6 DNC Timing, Ancillary Testing, Palliation & Donation

2.1 Pulse Oximetry, Pre/Postductal & Transcutaneous Monitoring

Key Takeaways Explain This Topic AI

Pre-ductal pulse oximetry must be placed on the right hand or wrist, reflecting arterial blood delivered upstream of the ductus arteriosus via the innominate artery.

A preductal-to-postductal saturation difference greater than about 5%–10% supports differential ductal shunting but does not by itself establish the cause; correlate with examination, blood pressure, gases, and echocardiography.

Transcutaneous sensors heat skin to arterialize local capillary flow. Use the device-, gestation-, and skin-specific temperature and rotation interval, verify against blood gases, and inspect fragile skin frequently.

Last updated: September 2026

2.1 Pulse Oximetry, Pre/Postductal & Transcutaneous Monitoring

Noninvasive gas exchange monitoring represents a primary competency in neonatal and pediatric respiratory care. Continuous evaluation of oxygenation and carbon dioxide dynamics guides clinical decision-making, ventilator adjustments, and acute resuscitation while minimizing patient handling, painful invasive procedures, and iatrogenic blood loss.

Pulse Oximetry Principles & Spectrophotometric Physics

Pulse oximetry (SpO2) utilizes spectrophotometry combined with optical photoplethysmography to noninvasively measure functional arterial hemoglobin oxygen saturation. The sensor houses two low-voltage light-emitting diodes (LEDs) and a photodetector photodiode:

Red Light (660 nm wavelength): Deoxygenated hemoglobin (RHb) absorbs significantly more light at 660 nm than oxygenated hemoglobin (HbO2).

Infrared Light (940 nm wavelength): Oxygenated hemoglobin (HbO2) absorbs substantially more light at 940 nm than deoxygenated hemoglobin.

The photodetector measures light transmitted through the pulsatile vascular bed. The microprocessor isolates the pulsatile signal ( AC component , representing expanding arterial blood volume during systole) from the non-pulsatile background ( DC component , representing venous blood, capillary blood, bone, and soft tissue). The ratio of red-to-infrared absorbance ratios (R = [AC660/DC660] / [AC940/DC940]) is correlated against empirical calibration curves to display SpO2.

Clinical Limitations & Dyshemoglobins

Carboxyhemoglobin (COHb): Standard two-wavelength pulse oximetry cannot distinguish COHb from oxyhemoglobin and may substantially overestimate useful oxygen saturation in carbon-monoxide exposure. Use co-oximetry when dyshemoglobinemia is suspected.

Methemoglobin (MetHb): Increasing MetHb tends to drive a conventional two-wavelength reading toward approximately 85% , regardless of whether true saturation is higher or lower. Confirm with co-oximetry.

Hypoperfusion and Shock: Hypothermia, vasoconstriction, shock, and vasoactive drugs can weaken the pulsatile signal. Judge the waveform or signal-quality indicator; a universal perfusion-index cutoff does not apply to every monitor.

Motion and optical artifact: Motion, ambient light, venous pulsation, nail products, skin pigmentation, probe malposition, and device limitations can bias or destabilize the value. Correlate the number with the waveform and the patient.

Pre-Ductal vs. Post-Ductal SpO2 Monitoring

In transitional neonatal physiology and congenital cardiovascular pathology, comparing simultaneous pre-ductal and post-ductal saturations is vital for assessing intracardiac and extracardiac right-to-left shunting. [Ascending Aorta]

  • │
  • ┌───────────┴───────────┐
  • │ │
  • [Innominate Artery] [Left Carotid & Subclavian]
  • │ │
  • Right Subclavian ▼
  • │ [Aortic Isthmus]
  • Right Arm/Wrist │
  • (PRE-DUCTAL) ├──◄ [Ductus Arteriosus]
  • │ (Pulmonary Trunk Shunt)
  • ▼
  • [Descending Aorta]
  • │
  • Lower Extremities
  • (POST-DUCTAL)
  • Vascular Anatomy & Probe Placement

Pre-Ductal Site: The right hand or right wrist . Blood flows from the left ventricle into the ascending aorta and branches first into the innominate (brachiocephalic) artery, which gives rise to the right subclavian and right common carotid arteries. This blood perfuses the right upper extremity prior to the insertion of the ductus arteriosus.

Post-Ductal Site: Use either foot . Lower-extremity blood reaches the descending aorta beyond the ductal insertion. The left hand is supplied from the aortic arch and is not a dependable postductal screening site because its relationship to ductal insertion varies.

Diagnostic Thresholds & Clinical Significance

A reproducible preductal saturation higher than the postductal saturation supports differential cyanosis and can reflect right-to-left ductal shunting, as in PPHN. The size of the difference varies with physiology and measurement quality; it is a clue rather than stand-alone confirmation. Reverse differential cyanosis—right hand lower than a foot—has a narrower congenital-cardiac differential. Correlate either pattern with simultaneous reliable signals, examination, blood gases, and echocardiography.

Clinical Finding Pre-Ductal SpO2 Post-Ductal SpO2 Pathophysiological Etiology

PPHN with right-to-left ductal flow Often higher Often lower Deoxygenated pulmonary-artery blood enters the descending aorta through the PDA. Absence of a gradient does not exclude PPHN when shunting is mainly atrial or lung disease dominates.

Critical left-sided obstruction May be higher May be lower Lower-body perfusion may depend on right-to-left ductal flow; weak femoral pulses, acidosis, and shock are crucial clues.

TGA with PPHN or arch obstruction May be lower May be higher Reverse differential cyanosis can occur when relatively oxygenated pulmonary-artery blood enters the descending aorta through the PDA.

Critical Congenital Heart Disease (CCHD) Screening Protocol

Follow the current jurisdictional and facility CCHD algorithm, generally at 24 hours of life or as late as possible before earlier discharge , using the right hand and one foot. Under the current U.S. CDC/AAP-aligned algorithm:

Pass: SpO2 is ≥95% in both the right hand and foot and the absolute difference is ≤3% .

Immediate fail: Any measurement is <90% .

Repeat once in 1 hour: Either site is 90%–94%, or the difference is >3%. A second measurement with either site <95% or a difference >3% is a failed screen.

A failed screen requires prompt evaluation for cardiac and noncardiac causes of hypoxemia; echocardiography is commonly part of that evaluation. A pass does not exclude every critical congenital heart defect.

Transcutaneous Gas Monitoring (tcPO2 & tcPCO2)

Transcutaneous monitoring provides continuous, noninvasive estimates of arterial oxygen and carbon dioxide tension by measuring the diffusion of gases through the skin to heated electrochemical sensors. [ Heated Sensor (42°C–44°C) ]

  • ───────────────────────────────── ◄ Contact Gel Layer
  • Stratum Corneum (Lipids melt)
  • ─────────────────────────────────
  • Epidermis (Avascular)
  • ─────────────────────────────────
  • Dermal Capillary Bed (Hyperemia) ◄ Dissolved O2 / CO2 Diffuses Upward
  • Operating Mechanisms & Thermodynamics

tcPO2 (Modified Clark Polarographic Electrode): Platinum cathode and silver anode immersed in an electrolyte solution. Applying a polarizing voltage of -600 to -800 mV reduces oxygen molecules, generating a current directly proportional to the number of reduced oxygen molecules.

tcPCO2 (Modified Severinghaus pH Electrode): Glass pH-sensitive electrode and reference silver/silver-chloride electrode separated from skin by a Teflon membrane and bicarbonate electrolyte solution. Diffusing CO2 hydrates to carbonic acid (H2CO3), dissociating into H+ and HCO3-, altering pH in proportion to PCO2.

Thermodynamic Hyperemization: The sensor heating element heats underlying cutaneous tissue to 42.0°C to 44.0°C . Heating liquefies the lipid bilayer of the stratum corneum, dilates dermal capillaries, increases local capillary blood flow (hyperemia) up to 7-fold, and shifts the oxyhemoglobin dissociation curve to the right, facilitating gas diffusion toward the skin surface.

Clinical Protocols & Temperature Selection

Temperature and dwell time: Select both from the monitor manufacturer's instructions and unit protocol, reducing temperature or dwell time for fragile or poorly perfused skin. Common neonatal settings are around 42°C–44°C, but they are not universal. Inspect after placement and at every rotation; erythema or skin injury requires immediate reassessment.

Calibration and membrane care: Follow the device schedule and recalibrate after indicated events such as membrane replacement or a failed calibration check. A fixed four-hour rule does not fit every monitor.

Interpretation: Heating increases local perfusion and changes gas tension, so monitor algorithms compensate for temperature and local metabolic CO2. Compare trends with an appropriate blood sample at initiation, after major clinical change, and whenever the value conflicts with the examination. Shock, edema, hypothermia, vasoactive drugs, thick skin, poor contact, and membrane problems can degrade agreement.